ReedCoor Raises $23 Million from China Investors for Novel NGS Technology

ReadCoor, a next generation sequencing spin-out from Harvard University, has closed an oversubscribed $23 million Series A financing from China-affiliated healthcare investors. The round was led by Decheng Capital and joined by Lilly Asia Ventures, Vivo Capital and Hansjörg Wyss. ReedCoor will commercialize an innovative FISSEQ (fluorescent in situ sequencing) technology that combines sequencing and imaging, simultaneously reading RNA sequences and visualizing their three-dimensional coordinates within whole cells and tissues. More details.... Share this with colleagues: // //